Repligen Corporation Market Cap ($10.40 Billion)
Market Cap & Net Worth: Repligen Corporation (RGEN)
Repligen Corporation market cap. Repligen Corporation (NASDAQ:RGEN) has a market capitalization of $10.40 Billion ($10.40 Billion) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2099 globally and #795 in its home market, demonstrating a -0.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Repligen Corporation's stock price $176.94 by its total outstanding shares 63490365 (63.49 Million). Also see how efficiently does Repligen Corporation generate cash for how efficiently the company converts equity into cash flow.
Repligen Corporation Market Cap History (2015–2026)
Repligen Corporation market cap history from 2015 to 2026. Data shows growth from $1.80 Billion to $11.23 Billion (17.21% CAGR). Check today's stock price for Repligen Corporation for real-time trading data and today's change.
Index Memberships
Repligen Corporation is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Biotechnology
BTK
|
$1.06 Trillion | 0.99% | #20 of 30 |
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.40% | #43 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.03% | #240 of 3165 |
|
S&P Midcap 400
MID
|
$3.34 Trillion | 0.24% | #101 of 401 |
Weight: Repligen Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Repligen Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Repligen Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Repligen Corporation (RGEN) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
14.09x
Repligen Corporation's market cap is 14.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
212.78x
Repligen Corporation's market cap is 212.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.96 Billion | $104.54 Million | $11.68 Million | 18.72x | 167.52x |
| 2017 | $2.30 Billion | $141.24 Million | $28.35 Million | 16.31x | 81.24x |
| 2018 | $3.35 Billion | $194.03 Million | $16.62 Million | 17.26x | 201.51x |
| 2019 | $5.87 Billion | $270.25 Million | $21.41 Million | 21.73x | 274.29x |
| 2020 | $12.17 Billion | $366.26 Million | $59.93 Million | 33.22x | 203.03x |
| 2021 | $16.81 Billion | $670.53 Million | $128.29 Million | 25.08x | 131.07x |
| 2022 | $10.75 Billion | $801.54 Million | $185.96 Million | 13.41x | 57.81x |
| 2023 | $11.42 Billion | $638.76 Million | $41.58 Million | 17.87x | 274.56x |
| 2024 | $9.14 Billion | $634.44 Million | -$25.51 Million | 14.40x | N/A |
| 2025 | $10.40 Billion | $738.26 Million | $48.89 Million | 14.09x | 212.78x |
Competitor Companies of RGEN by Market Capitalization
Companies near Repligen Corporation in the global market cap rankings as of November 1, 2026. Also see total assets of Repligen Corporation for a full breakdown of the balance sheet.
Key companies related to Repligen Corporation by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.77 Billion USD ( €85.34 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #421 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #536 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $432.01 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.77 Billion | €184.30 |
| #421 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €87.50 |
| #536 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Repligen Corporation (2015–2026)
Market capitalization of Repligen Corporation from 2015 to today. Between 2015 and today, Repligen Corporation's market cap moved from $1.80 Billion to $ 11.23 Billion, with a yearly change of 17.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.23 Billion | +7.98% |
| 2025 | $10.40 Billion | +13.84% |
| 2024 | $9.14 Billion | -19.94% |
| 2023 | $11.42 Billion | +6.20% |
| 2022 | $10.75 Billion | -36.07% |
| 2021 | $16.81 Billion | +38.20% |
| 2020 | $12.17 Billion | +107.17% |
| 2019 | $5.87 Billion | +75.39% |
| 2018 | $3.35 Billion | +45.37% |
| 2017 | $2.30 Billion | +17.72% |
| 2016 | $1.96 Billion | +8.94% |
| 2015 | $1.80 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Repligen Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.40 Billion USD |
| MoneyControl | $10.40 Billion USD |
| MarketWatch | $10.40 Billion USD |
| marketcap.company | $10.40 Billion USD |
| Reuters | $10.40 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, … Read more